Showing results (41-50 of 77) with videos related to
Sort By:
Pageof 8
Neuroscience Letters|December 18, 1985
Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicityR E Heikkila, W J Nicklas, I Vyas, et al.Nature|October 4, 1984
Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsR E Heikkila, L Manzino, F S Cabbat, et al.Pharmacology, Biochemistry, and Behavior|July 1, 1981
Potentiation by deprenil of 1-dopa induced circling in nigral-lesioned ratsR E Heikkila, F S Cabbat, L Manzino, et al.Neurology|January 1, 1981
Twin study of Parkinson diseaseR C Duvoisin, R Eldridge, A Williams, et al.Neurology|November 11, 1992
A 17th-century founder gives rise to a large north American pedigree of autosomal dominant spinocerebellar ataxia not linked to the SCA1 locus on chromosome 6A Lazzarini, T R Zimmerman, W G Johnson, et al.Clinical Neuropharmacology|February 1, 1988
Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's diseaseJ I Sage, L Schuh, R E Heikkila, et al.Journal of Neurochemistry|October 1, 1985
Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase BR E Heikkila, L Manzino, F S Cabbat, et al.Neurology|October 1, 1988
Risk factors for progressive supranuclear palsyP H Davis, L I Golbe, R C Duvoisin, et al.Neurology|July 1, 1988
Prevalence and natural history of progressive supranuclear palsyL I Golbe, P H Davis, B S Schoenberg, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1988
Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophyR C Duvoisin, W J Nicklas, V Ritchie, et al.Pageof 8